Penicillin
Sponsors
National Heart, Lung, and Blood Institute (NHLBI), Sanofi, Karlstad University, University of Melbourne, Universitat Internacional de Catalunya
Conditions
Anemia, Sickle CellHaematological Disorders
Malaria
Bacterial infection
PaediatricsHematologic DiseasesHemoglobinopathiesInfection (S. Pneumoniae)MastitisMaxillary Sinus DiseasePharyngitis
Phase 3
Penicillin Prophylaxis in Sickle Cell Disease (PROPS)
CompletedNCT00000585
Start: 1983-08-31End: 1994-10-31Updated: 2016-03-25
TELI TON - Telithromycin in Tonsillitis
TerminatedNCT00315042
Start: 2006-03-31End: 2006-08-31Updated: 2009-04-03
TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults
TerminatedNCT00315549
Start: 2006-02-28End: 2006-09-30Updated: 2009-04-03
Hydroxyurea – Pragmatic Reduction in Mortality and Economic burden: A multi-centre Phase III trial to investigate the efficacy of hydroxyurea for children with sickle cell anaemia when administered in a pragmatic fashion.
RecruitingPACTR202401802272880
Start: 2023-09-01Target: 1800Updated: 2026-01-27
Phase 4
Unknown Phase
Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding
CompletedNCT00405158
Start: 2002-01-31End: 2004-03-31Target: 210Updated: 2006-12-04
Long acting penicillin use in pregnant females with history of unexplained prelabor rupture of membranes
Active, not recruitingPACTR201902599405211
Start: 2019-02-15Target: 100Updated: 2026-01-27
Do Penicillin-allergic Patients Presents a High Risk of Sinus Lift Failure
RecruitingNCT06504888
Start: 2004-07-01End: 2024-12-31Target: 400Updated: 2024-07-17